Publications
Detailed Information
Prognostic role of body mass index in advanced small bowel adenocarcinoma patients receiving palliative chemotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Dae-Won | - |
dc.contributor.author | Lee, Kyung-Hun | - |
dc.contributor.author | Kim, Tae-Yong | - |
dc.contributor.author | Han, Sae-Won | - |
dc.contributor.author | Oh, Do-Youn | - |
dc.contributor.author | Im, Seock-Ah | - |
dc.contributor.author | Kim, Tae-You | - |
dc.contributor.author | Bang, Yung-Jue | - |
dc.date.accessioned | 2021-01-31T11:59:33Z | - |
dc.date.available | 2021-01-31T11:59:33Z | - |
dc.date.created | 2018-08-01 | - |
dc.date.created | 2018-08-01 | - |
dc.date.created | 2018-08-01 | - |
dc.date.issued | 2016-06 | - |
dc.identifier.citation | Nutrition and Cancer, Vol.68 No.5, pp.750-755 | - |
dc.identifier.issn | 0163-5581 | - |
dc.identifier.other | 41558 | - |
dc.identifier.uri | https://hdl.handle.net/10371/173189 | - |
dc.description.abstract | As small bowel adenocarcinoma (SBA) is a rare cancer worldwide, prognostic factors have not been clearly defined. The purpose of this study is to assess the prognostic role of clinicopathologic features, including body mass index (BMI), in patients with advanced SBA. A total of 28 consecutive patients with advanced SBA treated with palliative chemotherapy were retrospectively enrolled and analyzed. Clinicopathologic features, progression-free survival (PFS), and overall survival (OS) were compared according to BMI level. Eighteen patients had BMI < 25kg/m(2) (overweight/normal/underweight in Asian) and ten patients had BMI 25kg/m(2) (obese in Asian). Baseline characteristics were similar regardless of patient's BMI. Compared to patients with BMI < 25kg/m(2), patients with BMI 25kg/m(2) had higher response rate to chemotherapy (40.0% vs. 0%, P = 0.010), longer OS (11.2 vs. 7.0months, P = 0.018) and a tendency toward prolonged PFS (2.1 vs. 1.9months, P = 0.085). Multivariate analysis revealed that BMI 25kg/m(2) is an independent positive prognostic factor of OS (adjusted hazard ratio 0.35, P = 0.024). In conclusion, baseline BMI 25kg/m(2) has a positive prognostic role in patients with advanced SBA. | - |
dc.language | 영어 | - |
dc.publisher | Lawrence Erlbaum Associates Inc. | - |
dc.title | Prognostic role of body mass index in advanced small bowel adenocarcinoma patients receiving palliative chemotherapy | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 임석아 | - |
dc.identifier.doi | 10.1080/01635581.2016.1180413 | - |
dc.citation.journaltitle | Nutrition and Cancer | - |
dc.identifier.wosid | 000380883200004 | - |
dc.identifier.scopusid | 2-s2.0-84974727312 | - |
dc.citation.endpage | 755 | - |
dc.citation.number | 5 | - |
dc.citation.startpage | 750 | - |
dc.citation.volume | 68 | - |
dc.identifier.sci | 000380883200004 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Oh, Do-Youn | - |
dc.contributor.affiliatedAuthor | Im, Seock-Ah | - |
dc.contributor.affiliatedAuthor | Kim, Tae-You | - |
dc.contributor.affiliatedAuthor | Bang, Yung-Jue | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | COLON-CANCER | - |
dc.subject.keywordPlus | ADJUVANT CHEMOTHERAPY | - |
dc.subject.keywordPlus | SMALL-INTESTINE | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | RISK | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.